NMB Flashcards

1
Q

Steps in nerve transmission and depolarization

A

1) AP depolarizes terminal
2) Influx of calcium –> storage vesicles fuse with membrane
3) Release ACh into synaptic cleft to bind nicotinic receptor
4) ACh receptor undergoes conformational change
5) Cations flow through open receptor -> generates end plate potential
6) End plate potential generates depolarization (VG Na channels)
7) AP propogates along muscle and T-tubules
8) Release Ca into SR –> contraction
9) ACh rapidly hydrolyzed by AChE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ACh Nicotinic Receptor

A

5 subunits - 2 alpha, 1 beta, 1 episilom, 1 gamma

2 alpha subunits bind to ACh and cause change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Depolarizing blocker

A

closely resembles ACh, is able to bind and contract

  • not metabolized by AChE, so it lasts longer
  • This prolonged depolarization = relaxation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Phase I Block

A

channels cannot re-open until the end-plate repolarizes

-> end plate cannot repolarize as long as receptor is bound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phase II Block

A

After prolonged period of time, receptor changes to resemble a non-depolarizing block (unresponsive channel)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Non-depolarizing blocker

A

binds ACh recept at different site, doesn’t not cause the conformational change to open the ion channels, but does not allow true ACh to bind

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Extrajunctional receptors

A

new, naïve receptors that show an exaggerated response to depolarizing blockers and resistant to non-depolarizing blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Succinylcholine

A

depolarizer
It is 2 ACh molecules linked by covalent bond
- low Vd and poor lipid solubility
FAST onset most likely from overdosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sux metabolism

A

rapidly metabolized to succinylmonocholine by pseudocholinesterase

Hypothermia = decreases rate of hydrolysis -> prolongs block
- Low pseudoChE = prolong block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dibucaine number

A

measures amount of pseudocholinesterase function

~normal is 80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Sux drug interactions

A

Cholinesterase inhibitors = significantly prolongs sux blockade -> leads to increase [ACh]

Non-depolarizers = antagonize phase I block -> defasciculating dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Contraindications to Sux

A

1) Major burn
2) Prior stroke with residual deficits
3) Malignant Hyperthermia
4) Massive trauma
5) Prolonged immobilization
6) Hyperkalemia
7) Closed head injury (?)
8) Myopathies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sux on organ systems

A

CV: can stimulate all ACh receptors - the effect depends on the dominant system
MSK: fasciculations/myalgias from unsynchronized contraction - can see myoglobin in urine
Hyperkalemia: 0.5 mEq per dose, from the discharge of the nerve terminals and muscle fibers
GI: increased gastric pressure from ab wall fasciculations but also increase LES tone
CNS: increased ICP (theoretical)
Eye: increased intraocular pressure due to different receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nondepolarizers

A

steroidals vs benzylisoquinolones

  • use 2x ED95 dose for intubation
  • in general the more potent, the slower speed of onset
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Maintenance of Relaxation

A

helpful for surgical conditions, controlling ventilation and reducing the depth of anesthetic

  • lots of variability between patients
  • adding multiple relaxants is synergistic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hepatic Clearance

A

Pancuronium and Vecuronium

17
Q

Biliary Clearance

A

Vecuronium and Rocuronium

18
Q

Renal Clearance

A

Vecuronium

19
Q

General Pharm Characteristics

A

Hypothermia - prolongs blockade
Acidosis - prolongs blockade
Hypokalemia and Hypocalcemia - augments blockade
Neonates - more sensitive

20
Q

Atracurium

A

benzylisoquinolone
EXTENSIVELY metabolized that the pharmacokinetics are independent of renal/hepatic function
Ester hydrolysis - nonspecific esterases
Hoffman Elimination - non-enzymatic breakdown
DOSE: 0.5 mg/kg

21
Q

S.E. of Atracurium

A

Dose-dependent histamine release
Hypotension and tachycardia
Bronchospasm
Laudanosine toxicity - from Hoffman elimination = causes seizures
Free acid precipitate if given with alkaline drugs

22
Q

Cisatracurium

A

stereoisomer of atracurium (4x as potent)
- Hoffmann Elimination (due to potency, less Laudanosine toxicity)
DOSE: 0.1-0.15 mg/kg
NO HISTAMINE RELEASE

23
Q

Pancuronium

A

steroid ring
deacetylated in liver and excreted in urine, cirrhosis patients have longer actions
DOSE: 0.08-0.12 mg/kg

24
Q

S.E. of Pancuronium

A

Hypertension and tachycardia from vagal blockade
Arrhythmias
Allergies

25
Q

Vecuronium

A

steroidal with 1 less quaternary methyl group
Depends on biliary, hepatic and renal clearance
SHORT duration of action with rapid clearance
- Infusion = build up of 3-hydroxy metabolite and prolonged blockade
DOSE: 0.08-0.12 mg/kg

AVOID in renal failure

26
Q

Rocuronium

A

monoquaternary steroidal analog
NO Metabolism: biliary elimination
Duration of action not effected by renal clearance
NO active metabolite
DOSE: 0.45-0.9 mg/kg or 1.2 mg/kg for RSI given its rapid acting nature